Medical
About Us
Investor Relations
March 31, 2024
10.8%
Reagents that are effective for diagnosis and treatment of microorganism infection, such as mediums, antimicrobial susceptibily tests and rapid test reagents.
11.0%
Urine analysis test strips for testing various items such as occult blood, protein and glucose.
30.8%
Our major products are reagents and sampling bottles for fecal immunochemical tests for screening of colon cancer.
23.5%
Reagents to diagnose and measure infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens.
1.4%
Reagents for clinical chemistry tests that assist to measure and analyze biological components in blood serum and urine, with a focus on the test items that are related to lifestyle related diseases.
4.9%
Reagents for microbiological tests on food to detect food poisoning bacteria as well as reagents for environmental microbiological tests and equipment and devices to measure contamination of work environments.
6.6%
Reagents using the LAMP method, gene amplification technology.
11.2%
Various types of automated analyzers. They contract manufacturing specialized equipment that uses their in-house reagent.
Management
policy
Stock
Information